πŸ‡ΊπŸ‡Έ FDA
Patent

US 11634443

Treprostinil prodrugs

granted A61KA61K45/06A61K9/0019

Quick answer

US patent 11634443 (Treprostinil prodrugs) held by United Therapeutics Corporation expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K45/06, A61K9/0019, A61K9/0053, A61P